Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.8M Sell
10,500
-56
-0.5% -$19.2K 0.12% 157
2026
Q1
$3.71M Sell
10,556
-209
-2% -$74.5K 0.14% 134
2025
Q4
$3.52M Buy
10,765
+3,932
+58% +$1.25M 0.13% 145
2025
Q3
$1.93M Buy
6,833
+2,983
+77% +$865K 0.09% 172
2025
Q2
$1.07M Sell
3,850
-4,586
-54% -$1.3M 0.06% 215
2025
Q1
$2.63M Buy
8,436
+3,359
+66% +$992K 0.1% 153
2024
Q4
$1.32M Buy
+5,077
New +$1.51M 0.14% 89

Other funds holding AMGN

Integrity Alliance's AMGN Position: Q2 2026 in Review

Integrity Alliance reduced its Amgen (AMGN) stake by 0.53% in Q2 2026, selling an estimated $19.2K and leaving 10,500 shares worth $3.8M. The position accounts for 0.12% of the portfolio, ranked #157.

Integrity Alliance first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Integrity Alliance held 10,500 shares of Amgen worth $3.8M as of Q2 2026.
  • Integrity Alliance sold 56 Amgen shares in Q2 2026, an estimated $19.2K.
  • Amgen made up 0.12% of Integrity Alliance's portfolio in Q2 2026, its #157 holding.
  • Integrity Alliance first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Integrity Alliance's 13F filing for Q2 2026, filed 31 Jul 2026.